- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Sonoma Pharmaceuticals Inc (SNOA)
Track today's live Sonoma Pharmaceuticals (SNOA) share price, performance and key data on this page with our current NASDAQ:SNOA stock exchange information. Analyse interactive charts and historical data, check technical buy and sell signals in real time, and follow the Sonoma Pharmaceuticals share price on the NASDAQ exchange. Use the dropdown to switch exchange for the SNOA share price, head to our technical summary section, which provides analysis on Sonoma Pharmaceuticals share price buy/sell indicators using real-time data (or discuss the Sonoma Pharmaceuticals (SNOA) stock price today with other investors in the Sonoma Pharmaceuticals NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ:SNOA share price (ISIN: US83558L3033) to enhance your trading decisions with our free investment tools and resources.
What Is the Sonoma Pharmaceuticals Inc Share Price Today?
The Sonoma Pharmaceuticals share price today is 1.150.
What Is the Stock Symbol for Sonoma Pharmaceuticals Inc
The stock symbol (or 'ticker') for Sonoma Pharmaceuticals Inc is "SNOA."
What Stock Exchange Does Sonoma Pharmaceuticals Inc Trade On?
Sonoma Pharmaceuticals Inc is listed and trades on the NASDAQ stock exchange.
Is Sonoma Pharmaceuticals Inc a Good Stock to Buy?
Determining whether Sonoma Pharmaceuticals (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Use the dropdown to select a relevant stock exchange for the current NASDAQ:SNOA share price (ISIN: US83558L3033) to enhance your trading decisions with our free investment tools and resources.
What Is the Sonoma Pharmaceuticals Inc Share Price Today?
The Sonoma Pharmaceuticals share price today is 1.150.
What Is the Stock Symbol for Sonoma Pharmaceuticals Inc
The stock symbol (or 'ticker') for Sonoma Pharmaceuticals Inc is "SNOA."
What Stock Exchange Does Sonoma Pharmaceuticals Inc Trade On?
Sonoma Pharmaceuticals Inc is listed and trades on the NASDAQ stock exchange.
Is Sonoma Pharmaceuticals Inc a Good Stock to Buy?
Determining whether Sonoma Pharmaceuticals (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.120
1.210
52 wk Range
0.850
4.250
SNOA is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.1201.210
52 wk Range
0.8504.250
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
SNOA Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
Form DEF 14A SONOMA PHARMACEUTICALS For: 29 July- Investing.com
Form 8K Sonoma Pharmaceuticals Inc For: 19 August- Investing.com
Form 4 Sonoma Pharmaceuticals Inc For: 9 July- Investing.com
- Form 8K Sonoma Pharmaceuticals Inc For: 19 August
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Buy
Moving Averages
Neutral
Earnings
Latest Release
06/08/2026
EPS / Forecast
-0.09 / -0.30
Revenue / Forecast
6.4M / 4.99M
Compare SNOA to Peers and Sector
Metrics to compare | SNOA | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipSNOAPeersSector | |
|---|---|---|---|---|
P/E Ratio | −2.5x | 17.2x | −0.3x | |
PEG Ratio | −0.04 | −0.73 | 0.00 | |
Price/Book | 0.8x | 3.2x | 2.6x | |
Price / LTM Sales | 0.3x | 2.4x | 2.9x | |
Upside (Analyst Target) | - | 37.4% | 64.3% | |
Fair Value Upside | Unlock | 12.1% | 10.0% | Unlock |
Sonoma Pharmaceuticals, Inc. develops and produces stabilized hypochlorous acid (HOCl) products for wound and eye care, oral and nasal care, podiatry, animal health care, and dermatological conditions in the United States, Europe, Asia, Latin America, and internationally. It offers Lumacyn, a skin toner; Regenacyn, a prescription scar gel; Reliefacyn to alleviate red bumps, rashes, shallow skin fisures, sunburn, peeling, and eczema/atopic dermatitis; Gramaderm for the treatment of topical mild to moderate acne; Epicyn, an antimicrobial facial cleanser; Levicyn, an HOCl based prescription and over-the-counter product used to relieve skin irritations, lacerations, abrasions, and burns; Celacyn, a scar management gel; and Pediacyn, an atopic dermatitis hydrogel. The company also provides Microcyn, a HOCl-based topical line of products designed to stimulate expedited healing by targeting a range of pathogens; Ocucyn eyelid and eyelash cleanser; Ocudox for eye care; Sinudox for nasal irrigation; Microdacyn60 oral care solution to treat mouth and throat infections; and Podiacyn, a foot care product. In addition, it offers MicrocynAH, an HOCl-based solution used to relieve common symptoms of hot spots, scratches, skin rashes, post-surgical sites, and irritated animal skin; MicrocynVS, an animal care product; Nanocyn, a hospital-grade disinfectant; Acuicyn, a solution for the treatment of blepharitis and the daily hygiene of eyelids and lashes; MucoClyns, a disinfectant; and Endocyn, a root canal irrigation solution. The company was formerly known as Oculus Innovative Sciences, Inc. and changed its name to Sonoma Pharmaceuticals, Inc. in December 2016. Sonoma Pharmaceuticals, Inc. was incorporated in 1999 and is based in Boulder, Colorado.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Sonoma Pharmaceuticals (NASDAQ: SNOA) Share Price Today?
The Sonoma Pharmaceuticals stock price today is 1.150 USD.
What Stock Exchange Does Sonoma Pharmaceuticals (SNOA) Trade On?
Sonoma Pharmaceuticals is listed and trades on the Nasdaq Stock Exchange.
What Is the Ticker (Stock Symbol) for Sonoma Pharmaceuticals?
The stock symbol (also called a 'ticker') for Sonoma Pharmaceuticals is "SNOA."
What Is the Current Sonoma Pharmaceuticals Market Capitalisation?
As of today, Sonoma Pharmaceuticals (NASDAQ: SNOA) market cap is 5.670M USD.
What Is Sonoma Pharmaceuticals's (SNOA) Earnings Per Share (TTM)?
The Sonoma Pharmaceuticals EPS is currently -1.01 (Trailing Twelve Months).
When Is the Next Sonoma Pharmaceuticals Earnings Date?
Sonoma Pharmaceuticals's next earnings report will be released on 16/11/2026.
Is SNOA a Buy or Sell From a Technical Analyst Perspective?
Based on today's Sonoma Pharmaceuticals moving averages and other technical indicators, the daily buy/sell signal for SNOA stock is Strong Sell.
How Many Times Has Sonoma Pharmaceuticals Stock Split?
Sonoma Pharmaceuticals has split 4 times. (See the SNOA stock split history page for full effective split date and price information.)
How Many Employees Does Sonoma Pharmaceuticals Have?
Sonoma Pharmaceuticals has 10 employees, based on their latest Companies House report.
What is the current trading status of Sonoma Pharmaceuticals (NASDAQ: SNOA)?
As of 15/10/2026, Sonoma Pharmaceuticals (SNOA) is trading at a share price of 1.150 USD, with a previous close of 1.160 USD. The stock has fluctuated within a day range of 1.120 USD to 1.210 USD, while its 52-week range spans from 0.850 USD to 4.250 USD.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.